Introduction {#S0001}
============

Thyroid nodules are exceedingly common, with a reported prevalence of 20--67% on ultrasound (US) examinations and up to 25% on contrast-enhanced thoracic computed tomography (CT) scans.[@CIT0001] Calcification is a common imaging finding observed in thyroid nodules, which accounts for 15.7--28.9% of benign nodules and 49.6--65.9% of malignant nodules on US examinations.[@CIT0002],[@CIT0003] The diagnostic value of microcalcifications for malignant nodules has been widely accepted.[@CIT0002]--[@CIT0004] However, coarse calcifications often cause obvious echo attenuation, which affects the visualization of internal and posterior structures of the calcified nodules. Moreover, coarse calcifications are often accompanied by fibrosis in the surrounding area, which results in uneven echo and fails to provide sufficient information for proper diagnosis. Therefore, thyroid nodules with coarse calcifications are usually classified as the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) 4 or 5,[@CIT0005]--[@CIT0008] hence cause significant confusion among clinicians and patients, and even unnecessary surgical trauma.

Fine-needle aspiration (FNA) is often recommended for ACR TI-RADS 4 or 5 nodules,[@CIT0005],[@CIT0009],[@CIT0010] which is considered the most effective practical technique to reach a definitive diagnosis for most thyroid nodules.[@CIT0011],[@CIT0012] However, for thyroid nodules with coarse calcifications, particularly those with thick-walled annular calcifications, it is difficult to penetrate the hard calcified area or obtain sufficient cytology specimens, even if penetration is achieved.[@CIT0013]--[@CIT0015] This results in nondiagnostic and inconclusive rates on FNA up to 27.2--53.8% and 42.2--57.7%, respectively.[@CIT0015],[@CIT0016] Compared with FNA, coarse needle biopsy (CNB) is often able to obtain adequate cytological specimens with higher specificity.[@CIT0015],[@CIT0017] However, more traumas are involved with CNB procedures.

Although CT is inadequate for the diagnosis of microscopic and diffuse lesions in the thyroid, it is able to fully reveal the internal and surrounding structures of nodules with coarse calcifications due to the absence of echo attenuation. In our previous studies, we analyzed CT histogram characteristics and artifacts of solitary coarse calcified nodules respectively. We found that both the proportion of voxels \< 1150 Hounsfield units (HU) no more than 98.4% and the presence of artifacts around calcifications on noncontrast CT could contribute to the diagnosis of benign nodules.[@CIT0018],[@CIT0019] However, the operation and analysis of CT histogram is complex and requires special measurement software, while evaluating artifact is a subjective process. Therefore, both are difficult to be widely applied. We suggest that HU value, similar to CT histogram and artifact, could also reflect the internal structure and density characteristics inside calcified nodules to a certain extent, from which their properties could be assessed.

To the best of our knowledge, no previous studies have investigated maximum Hounsfield unit values (MHUVs) of thyroid nodules with coarse calcifications on noncontrast CT. Based on our previous studies,[@CIT0018]--[@CIT0022] the present study aimed to explore the diagnostic role of average Hounsfield unit values (AHUVs) and MHUVs in ACR TI-RADS 4-5 nodules, so as to provide an important basis for further diagnosis and treatment in the clinic.

Patients and Methods {#S0002}
====================

Patients {#S0002-S2001}
--------

This study involved all patients with thyroid nodules who underwent surgery in our hospital between August 2017 and August 2019. The inclusion criteria were as follows: (1) ACR TI-RADS 4-5 thyroid nodules, (2) CT scan performed before surgery, (3) short diameter of the calcified area of nodule ≥ 4 mm and (4) pathological verification after surgery. The exclusion criteria were as follows: (1) nodules that were not clearly visible on CT images due to poor image quality or those with other thyroid diseases, and (2) patients with incomplete clinical and imaging data. Ultimately, a total of 207 patients (36 males and 171 females, aged 54.0 ± 11.0 years, range 28--82 years) with 216 thyroid coarse calcified nodules were included in the study. This retrospective study was approved by the Ethics Committee of the Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine (Hangzhou, Zhejiang Province, People's Republic of China). Due to the retrospective nature of the study and the use of anonymized patient data, written informed consent for participation was not required, in accordance with the national legislation and institutional requirements.

Pathology {#S0002-S2002}
---------

All 216 ACR TI-RADS 4-5 thyroid nodules with coarse calcifications from the 207 patients had a conclusive pathological diagnosis confirmed by senior pathologists. Archived tissue specimens were cut into sections (5 μm thick) and fixed in 10% neutral formalin and stained using the hematoxylin and eosin method. The tissue sections were then examined under a light microscope.

CT Examination {#S0002-S2003}
--------------

All patients underwent CT using a 16-slice spiral CT scanner (Lightspeed, GE Healthcare, Milwaukee, WI, USA). Patients were positioned supine and scanned from the base of the skull to the upper edge of the aortic arch. The scan parameters were as follows: power, 120 kV; current, 250 mA; collimation, 0.625 mm × l6 mm; and pitch, 0.938. The rotation time of the rack was 0.5 s and reconstruction thickness (ie, slice thickness) was 3.75 mm.

Image Analysis {#S0002-S2004}
--------------

CT images were reviewed independently by two radiologists (PYW and NDJ) with 5 and 8 years' working experience, respectively. The radiologists were blinded to clinical information, other imaging results, and pathological data of the patients. They measured the HU values of nodules on the Picture Archiving and Communication Systems Workstation. The CT value of the calcified area was measured under soft tissue window width (WW) and window position (WL) (WW: 350, WL: 40). A round or elliptical area was used to delineate the region of interest (ROI). For measuring AHUV, the ROI should be as large as possible and avoid the non-calcified area. The HU values in the maximum and sub-maximal sections of the calcified area were measured, from which the larger was selected ([Figure 1A](#F0001){ref-type="fig"} and [B](#F0001){ref-type="fig"}). For measuring MHUV, the ROI should extend beyond the edge of each section of calcified area, and avoid covering other calcifications outside the nodules or the surrounding bone structure. The maximum measurement result was considered the MHUV of nodule ([Figure 2A](#F0002){ref-type="fig"} and [B](#F0002){ref-type="fig"}). The AHUVs and MHUVs measured by the two radiologists respectively were taken for interobserver consistency analysis. The mean values of AHUVs and MHUVs measured by the two radiologists were used for analysis of diagnostic performances.Figure 1Method for measuring AHUV.**Notes:** (**A**) AHUV of the nodule was 879.3 HU, and the nodule was surgically confirmed as nodular goiter. (**B**) AHUV of the nodule was 463.8 HU, and the nodule was surgically confirmed as papillary thyroid carcinoma.**Abbreviation:** AHUV, average Hounsfield unit value.Figure 2Method for measuring MHUV.**Notes:** (**A**) MHUV of the nodule was 1410.0 HU, and the pathology was nodular goiter. (**B**) MHUV of the nodule was 805.0 HU, and the pathology was papillary thyroid carcinoma. **Abbreviation:** MHUV, maximum Hounsfield unit value.

Statistical Analyses {#S0002-S2005}
--------------------

Statistical analyses were performed using SPSS 19.0 (IBM Corporation, Armonk, NY, USA) and MedCalc 15.8 (MedCalc, Ostend, Belgium). Variables with normal distribution were expressed as mean ± standard deviation, while variables with non-normal distribution were expressed as median \[interquartile range (IQR)\]. Categorical variables were analyzed using the chi-squared test or the Fisher's exact test, while continuous variables were compared using the independent samples *t*-test or the Wilcoxon rank sum test. Receiver operating characteristic (ROC) curves were used to analyze the diagnostic value of AHUVs and MHUVs. The best cut-off values were obtained from ROC analyses. Diagnostic performances were assessed according to the area under the ROC curve (AUC), sensitivity, and specificity. Cohen's kappa coefficient was used to assess the consistency between the two radiologists. Differences with *P* \< 0.05 were considered to be statistically significant.

Results {#S0003}
=======

During the study period, a total of 207 patients with 216 ACR TI-RADS 4-5 thyroid nodules with coarse calcifications were enrolled according to the selection criteria. The typical US images are shown in [Figure 3A](#F0003){ref-type="fig"} and [B](#F0003){ref-type="fig"}. All 170 benign nodules with coarse calcifications from 163 patients were nodular goiters, while 45 malignant nodules from 44 patients were papillary thyroid carcinomas, and 1 nodule was follicular carcinoma. The typical pathological images are shown in [Figure 4A](#F0004){ref-type="fig"} and [B](#F0004){ref-type="fig"}. There were 25 males and 138 females with benign nodules, and 11 males and 33 females with malignant nodules. The mean age of the male patients was 55.95 ± 12.14 years and 53.48 ± 11.02 years for females. The average lesion size of benign and malignant nodules was 10.90 mm (IQR, 7.43--14.70 mm) and 8.70 mm (IQR, 6.80--13.00 mm), respectively. The sexes, ages and lesion sizes showed no significant differences between benign and malignant nodules. The AHUV for benign nodules was 791 HU (IQR, 543--1025 HU) and for malignant nodules was 486 HU (IQR, 406--670 HU). The MHUV for benign nodules was 1084 HU (IQR, 717--1477 HU) and for malignant nodules was 677 HU (IQR, 441--986 HU).The differences were significant in terms of AHUVs and MHUVs ([Table 1](#T0001){ref-type="table"}).Table 1General Data and Hounsfield Unit ValuesVariableNodules*P* valueBenignMalignantSex, N (%) Male25 (15.24)11 (25.00)0.133 Female138 (84.76)33 (75.00)Age, years55.95 ± 12.1453.48 ± 11.020.707Size, mm10.90 (7.43--14.70)8.70 (6.80--13.00)0.069AHUV, HU791 (543--1025)486 (406--670)\<0.001MHUV, HU1084 (717--1477)677 (441--986)\<0.001[^2][^3] Figure 3Typical ultrasound images for ACR TI-RADS 4−5 nodules with coarse calcifications, which revealed calcifications were interrupted, accompanied by significant echo attenuation in the posterior area.**Notes:** (**A**) The nodule was classified to ACR TI-RADS 4, and the pathology was nodular goiter. (**B**) The nodule was classified to ACR TI-RADS 5, and the pathology was papillary thyroid carcinoma. **Abbreviation:** ACR TI-RADS, the American College of Radiology Thyroid Imaging Reporting and Data System.Figure 4Typical pathological images.**Notes:** (**A**) Pathological image (original magnification ×20) of nodular goiter revealing that calcifications (black arrow) surrounded by fibrosis (white arrow). (**B**) Pathological image (original magnification ×30) of papillary thyroid carcinoma revealing calcifications (black arrow) and fibrosis (white arrow) separated by cancer tissues (black pentagram).

For predicting the benign nodules with coarse calcifications, the AUCs for AHUVs and MHUVs were 0.759 (95% confidence interval \[CI\], 0.697--0.815) and 0.732 (95% CI, 0.667--0.790), respectively ([Figure 5](#F0005){ref-type="fig"}). When the maximum values of Jordan index for AHUVs and MHUVs were 0.415 and 0.362, the cut-off values were 627.5 HU and 806.0 HU, with sensitivities of 67.6% and 68.8%, specificities of 73.9% and 67.4%, respectively. The sensitivity and specificity of the combination were 68.8% and 76.1%.Figure 5ROC curves of AHUV and MHUV.**Abbreviations:** ROC, receiver operating characteristic; AHUV, average Hounsfield unit value; MHUV, maximum Hounsfield unit value.

The two radiologists demonstrated good agreement regarding AHUVs (k = 0.840; 95% CI, 0.738--0.925). The MHUVs measured by the two radiologists are all consistent (k = 1).

Discussion {#S0004}
==========

To our knowledge, this was the first study to use AHUVs and MHUVs on noncontrast CT to analyze ACR TI-RADS 4−5 nodules with coarse calcifications. According to our measurement method, the two radiologists demonstrated good agreement regarding AHUVs, and MHUVs measured by the two radiologists are all consistent. Our results demonstrated that the AHUVs and MHUVs of benign nodules were significantly higher than those of malignant nodules. The AUCs of AHUVs and MHUVs for predicting benign nodules with coarse calcifications were similar (0.759 and 0.732, respectively) and the cut-off values were 627.5 HU and 806.0 HU, with sensitivities of 67.6% and 68.8%, and specificities of 73.9% and 67.4%, respectively. With the increase in AHUVs and MHUVs, the specificity for benign diagnosis increased. The combination of AHUV and MHUV could further improve the specificity.

Pathologically, there is significant difference between benign and malignant thyroid coarse calcifications. Most benign calcifications or ossifications are continuous and manifest as dense plates, blocks, strips, arcs, or nodules. The mechanism is associated with sufficient and mature accumulation of calcium salts. However, malignant coarse calcifications are distributed in loose, intermittent spots or dots, even in honeycomb shape. The mechanism is related to the insufficient accumulation of calcium salts and continuous destruction by malignant tumor cells during the accumulation process.[@CIT0018],[@CIT0019],[@CIT0023] Therefore, these pathological differences between benign and malignant coarse calcifications are reflected as different densities on plain film or CT imaging.

In 1958, Holtz and Powers first proposed that the density of thyroid benign calcifications was significantly higher than that of malignant calcifications in X-ray examinations.[@CIT0024] However, due to the limitations of imaging technologies at that time, further quantitative analysis was impossible. In 2015, we estimated the diagnostic value of CT artifacts for solitary coarse calcifications in thyroid nodules, and found that the presence of artifacts was more supportive of the diagnosis of benign nodules.[@CIT0018] However, there are shortcomings in judging artifacts, such as strong subjectivity. Yang et al analyzed 41 cases with thyroid solitary calcified nodules and 55 cases with solely coarse calcified surrounded by a low-density focus. They found that the amplification of lesions after contrast enhancement was an independent risk factor for cancer.[@CIT0025] However, the delineation of ROI and judgement of lesion size were not specifically addressed, and the lesion sizes were not quantified in their study. In 2017, Kim et al analyzed 42 malignant and 19 benign coarse calcified nodules according to HU values, and found that the HU values for thyroid benign calcified nodules were higher than those for malignant calcified nodules.[@CIT0026] However, their sample cohort was small, and they did not further determine a cut-off HU value or analyze diagnostic efficacy. The sample size of benign nodules in our study was larger than that reported by Kim et al.[@CIT0026] We proposed MHUV for the first time and evaluated the ACR TI-RADS 4-5 thyroid coarse calcified nodules together with AHUVs. Our results demonstrated that the AHUVs and MHUVs of benign nodules were significantly higher than those of malignant nodules.

To increase the repeatability of the experiment in the present study, we defined the measurement methods for AHUVs and MHUVs. Although there was good consistency between the two radiologists in the process of measuring AHUVs, the measurement process was relatively complex, especially regarding the size of the ROI and the selection of the measurement area. However, the measurement of MHUVs was relatively simple, and the ROI only needed to cover the entire calcified nodule. The results show MHUVs measured by the two radiologists were all consistent. Our results demonstrated that the diagnostic efficiency of AHUVs was just slightly better than that of MHUVs when the maximum Jordan index was considered. The combination of both could further improve the specificity. However, there were still some deficiencies in specificity. To reduce the rate of misdiagnosis, therefore, higher specificity is needed. When the specificities of both were 91.3%, the sensitivity of MHUV (36.5%) was higher than AHUV (31.2%).

Our results showed that AHUVs and MHUVs were of great value in differentiating benignity from malignancy in ACR TI-RADS 4-5 nodules with coarse calcifications. However, it should be noted that performing noncontrast CT is not routinely feasible for all thyroid diseases, especially for microscopic and diffuse lesions, since its soft tissue resolution is limited, and it is relatively expensive and may be associated to harmful effects (ie use of ionising radiation).

The present investigation had several limitations. First, selection bias was inevitable because this was a retrospective study and the data were obtained from a single medical institute. Second, the combination of multiple CT signs may be more valuable for the qualitative diagnosis of nodules with coarse calcifications. However, this investigation aimed to introduce the diagnostic role of AHUV and MHUV on noncontrast CT, and further study will be done in combination with other CT signs. Finally, because the slice thickness in the CT scans was 3.75 mm, to avoid the influence of partial volume effect, ACR TI-RADS 4-5 nodules with a short diameter of calcified area \< 4 mm were not included. Hence, whether our results are applicable to these nodules needs further study with a larger sample size.

Conclusion {#S0005}
==========

AHUVs and MHUVs were helpful in differentiating benignity from malignancy in ACR TI-RADS 4-5 nodules with coarse calcifications. The former demonstrated greater AUC and specificity, while the latter had higher sensitivity and was more convenient in operation. The combination of both could further improve the specificity. This may provide an important basis for reducing misdiagnosis and unnecessary aspiration or surgical trauma.
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